Tuscaloosa VA Medical Center, Tuscaloosa, AL
Tuscaloosa, Alabama, United States
Veterans hospital in Tuscaloosa, Alabama
3701 Loop Rd, Tuscaloosa, AL 35404
About Tuscaloosa VA Medical Center, Tuscaloosa, AL
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
VA Office of Research and Development
16
US Department of Veterans Affairs
9
Tuscaloosa Research & Education Advancement Corporation
6
National Institute of Mental Health (NIMH)
3
Otsuka Pharmaceutical Development & Commercialization, Inc.
2
Tonix Pharmaceuticals, Inc.
2
Auburn University
1
Lori Davis, MD
1
Michael E. DeBakey VA Medical Center
1
Pharmacotherapies for Alcohol and Substance Use Disorders Alliance
1
Sucampo Pharma Americas, LLC
1
Clinical Trials at Tuscaloosa VA Medical Center, Tuscaloosa, AL
During the past decade, Tuscaloosa VA Medical Center, Tuscaloosa, AL conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 16 clinical trials were completed, i.e. on
average, 123.1% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 4 clinical trials were completed. i.e. 57.1%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
To Determine if Olanzapine is More Cost Effective Than Haloperidol for the Treatment of Schizophrenia
1998-03-01
Completed
600
Risperidone Treatment for Military Service Related Chronic Post Traumatic Stress Disorder
2006-10-01
2011-01-01
Completed
296
Divalproex Sodium in the Treatment of PTSD (Post-Traumatic Stress Disorder)
2003-10-01
2005-09-01
Completed
101
Integrating Clinical Practice Guidelines for Smoking Cessation Into Mental Health Care for Veterans With Posttraumatic Stress Disorder
2004-07-01
2009-06-01
Completed
943
Long-Acting Injectable Risperidone in the Treatment of Schizophrenia
2006-09-01
2009-09-01
Completed
382
Characterization of the Use of Antipsychotics in PTSD During the Past Seven Years
2005-07-01
2005-09-01
Completed
99
Characterization of the Use of Antipsychotics in Posttraumatic Stress Disorder During the Past Decade
2005-09-01
2005-09-30
Withdrawn
0
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Tuscaloosa VA Medical Center, Tuscaloosa, AL" #1 sponsor was "VA Office of Research and Development" with 16 trials, followed by "US Department of Veterans Affairs" with 9 trials
sponsored, "Tuscaloosa Research & Education Advancement Corporation" with 6 trials sponsored, "National Institute of Mental Health (NIMH)" with 3 trials sponsored and "Otsuka Pharmaceutical Development & Commercialization, Inc."
with 3 trials sponsored. Other sponsors include 2 different institutions and
companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Tuscaloosa VA Medical Center, Tuscaloosa, AL"
#1 collaborator was "Tuscaloosa Veterans Affairs Medical Center" with 3 trials as a collaborator, "Acorda Therapeutics" with 2 trials as a collaborator, "Janssen, LP" with 2 trials as a collaborator, "Ralph H. Johnson VA Medical Center" with 2 trials as a collaborator and "United States Department of Defense" with 2 trials as a collaborator. Other collaborators include 16 different institutions and companies that were
collaborators in the rest 26 trials.
Clinical Trials Conditions at Tuscaloosa VA Medical Center, Tuscaloosa, AL
According to Clinical.Site data, the most researched conditions in "Tuscaloosa VA Medical Center, Tuscaloosa, AL" are
"PTSD" (8 trials), "Posttraumatic Stress Disorder" (5 trials), "Dementia" (3 trials), "Major Depressive Disorder" (3 trials) and "Alzheimer's Disease" (2 trials). Many other conditions were trialed in "Tuscaloosa VA Medical Center, Tuscaloosa, AL" in a lesser frequency.
Clinical Trials Intervention Types at Tuscaloosa VA Medical Center, Tuscaloosa, AL
Most popular intervention types in "Tuscaloosa VA Medical Center, Tuscaloosa, AL" are "Drug" (24 trials), "Behavioral" (12 trials) and "Other" (7 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (9 trials), "Individual Placement and Support (IPS)" (3 trials), "Olanzapine" (2 trials), "Quetiapine" (2 trials) and "Risperidone" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Tuscaloosa VA Medical Center, Tuscaloosa, AL
The vast majority of trials in "Tuscaloosa VA Medical Center, Tuscaloosa, AL" are
43 trials for "All" genders.
Clinical Trials Status at Tuscaloosa VA Medical Center, Tuscaloosa, AL
Currently, there are NaN active trials in "Tuscaloosa VA Medical Center, Tuscaloosa, AL".
1 are not yet recruiting,
5 are recruiting,
undefined are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 31 completed trials in Tuscaloosa VA Medical Center, Tuscaloosa, AL,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Tuscaloosa VA Medical Center, Tuscaloosa, AL, 0 "Phase 1"
clinical trials were conducted, 8 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 9 trials, and there were
also 16 trials that are defined as “Not Applicable".